Watch this webinar to gain insights into current market trends in dry powders for inhalation, the key capsule characteristics that determine performance and the fundamental physical characteristics of spray-dried and lactose-based powders that contribute to the efficiency of the encapsulation process.
Summary: In this Q&A article, experts discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.
Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.
Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or…
Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.
